Abstract
Eosinophilic oesophagitis is a relapsing inflammatory disorder involving oesophagus identified over 30 years ago. Diagnosis is made by upper gastrointestinal endoscopy and oesophageal biopsies. There is huge variation in management practices across the globe. Therapeutic options include the use of proton pump inhibitors, topical steroids, and elimination diet. Biologics and immunomodulator drugs are being explored but not yet recommended in children. Long-term treatment may be required to control symptoms and to prevent complications such as fibrosis/stricture.
Conclusion: Even though clinicians have better understanding of eosinophilic oesophagitis, further research is warranted in exploring the unmet needs of developing a highly sensitive non-invasive biomarker for its diagnosis and response to treatment along with a robust and easily deliverable therapeutic option.
What is Known: •Incidence of eosinophilic oesophagitis has increased over the recent years. •Diagnostic confirmation requires upper gastrointestinal endoscopy and therapeutic options include elimination diet and/or topical steroids. | |
What is New: •There is a lack of consensus ion management strategy with wide variation across the globe. •There is a need to develop a highly reliable and non-invasive biomarker to diagnose eosinophilic oesophagitis and to monitor the response to treatment. |
Similar content being viewed by others
Availability of data and material
Submitted online.
Abbreviations
- EoE:
-
Eosinophilic oesophagitis
- GORD:
-
Gastro-oesophageal reflux disease
- OGD:
-
Oesophago-gastro-duodenoscopy
- PPI:
-
Proton pump inhibitors
- RAT:
-
Radio Allergo Sorbent Test
- SPT:
-
Skin Prick Test
References
Attwood SE, Smyrk TC, Demeester TR, et al (1993) Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 38:109–16. https://doi.org/10.1007/BF01296781pmidhttp://www.ncbi.nlm.nih.gov/pubmed/8420741
CPT. International statistical classification of diseases and related health problems: ICD-10. Available: https://coder.aapc.com/icd-10-codes/K20.0#:~:text=ICD%2D10%20code%20K20.,Diseases%20of%20the%20digestive%20system%20 [Accessed 30 Mar 2021] https://icd.codes/icd10cm/K20 [Accessed 25 Jun 2021].
Furuta GT, Liacouras CA, Collins MH, et al (2007) Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133:1342–1363
Attwood S, Epstein J (2020) Eosinophilic oesophagitis: recent advances and practical management. Frontline Gastroenterology flgastro-2019–101313; https://doi.org/10.1136/flgastro-2019-101313
Navarro P, Arias Ángel, Arias-González L, et al (2019) Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther 49:1116–25. https://doi.org/10.1111/apt.15231pmidhttp://www.ncbi.nlm.nih.gov/pubmed/30887555
Dellon ES (2019) Editorial: the evolving epidemiology of EoE-up, up, and away? Aliment Pharmacol Ther 49(11):1448–1449. https://doi.org/10.1111/apt.15252
Dellon ES (2014) Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am 43(2):201–218. https://doi.org/10.1016/j.gtc.2014.02.002
Vinit C, Dieme A, Courbage S, et al (2019) Eosinophilic esophagitis: pathophysiology, diagnosis, and management. Arch Pediatr 26:182–190. https://doi.org/10.1016/j.arcped.2019.02.005
Davis BP (2018) Pathophysiology of eosinophilic esophagitis. Clin Rev Allergy Immunol 55:19–42. https://doi.org/10.1007/s12016-017-8665-9
Spergel JM (2015) An Allergist’s perspective to the evaluation of eosinophilic esophagitis. Best Pract Res Clin Gastroenterol 29(5):771–781
Ryu S, Lee KH, Tizaoui K, et al (2020) Pathogenesis of eosinophilic esophagitis: a comprehensive review of the genetic and molecular aspects. Int J Mol Sci 21(19):7253. https://doi.org/10.3390/ijms21197253
Martin LJ, He H, Collins MH, et al (2018) Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol 141(5):1690–1698
Kottyan LC, Davis BP, Sherrill JD, et al (2014) Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 46(8):895–900
Shaheen NJ, Mukkada V, Eichinger CS, Schofield H, Todorova L, Falk GW (2018) Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course. Dis Esophagus 31(8):doy015. https://doi.org/10.1093/dote/doy015
Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, Liacouras CA (2009) 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 48:30–36
DeBrosse CW, Franciosi JP, King EC, Butz BK, Greenberg AB, Collins MH, Abonia JP, Assa’ad A, Putnam PE, Rothenberg ME (2011) Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol 128:132–138
Butz BK, Wen T, Gleich GJ, et al (2014) Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology 147:324–333
Miehlke S, Hruz P, Vieth M, et al (2016) A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut 65:390–399
Lucendo AJ, Arias A, Molina-Infante J (2016) Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 14:13–22
Dellon ES, Hirano I (2018) Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 154(2):319–332
Choudhury S, Kozielski R, Hua J, Wilding GE, Baker S (2000) Do histological features of eosinophilic esophagitis in children correlate with peripheral eosinophils? JPGN 70(5):604–607
Lucendo AJ, Molina-Infante J, Arias Ángel, et al (2017) Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J 5:335–58. https://doi.org/10.1177/2050640616689525pmidhttp://www.ncbi.nlm.nih.gov/pubmed/2850774
Hirano I, Moy N, Heckman MG, et al (2013) Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 62:489–95. doi:https://doi.org/10.1136/gutjnl-2011-301817pmidhttp://www.ncbi.nlm.nih.gov/pubmed/22619364
Hoofien A, Dias JA, Malamisura M, et al (2019) Pediatric eosinophilic esophagitis: results of the European retrospective pediatric eosinophilic esophagitis registry (RetroPEER). J Pediatr Gastroenterol Nutr 68:552–8. https://doi.org/10.1097/MPG.0000000000002215pmidhttp://www.ncbi.nlm.nih.gov/pubmed/30540712
Papadopoulou A, Koletzko S, Heuschkel R, et al (2014) Management guidelines of eosinophilic esophagitis in childhood. JPGN 58:107–118
Gupta SK, Vitanza JM, Collins MH (2015) Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 13:66–76. https://doi.org/10.1016/j.cgh.2014.05.021pmidhttp://www.ncbi.nlm.nih.gov/pubmed/24907502
Lucendo AJ, Miehlke S, Schlag C, et al (2019) Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology 157:74–86. https://doi.org/10.1053/j.gastro.2019.03.025pmidhttp://www.ncbi.nlm.nih.gov/pubmed/30922997
Visaggi P, Savarino E, Sciume G, et al (2021) Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults. Therap Adv Gastroenterol 31(14):1756284820980860. https://doi.org/10.1177/1756284820980860.eCollection2021
Spergel JM, Andrews T, Brown-Whitehorn TF, et al (2005) Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 95:336–343
Tourlamain G, Garcia-Puig R, Gutiérrez-Junquera C, et al (2020) Differences in management of eosinophilic esophagitis in Europe: an assessment of current practice. JPGN 71(1):83–90
Author information
Authors and Affiliations
Contributions
All the authors (MA, NM, and TM) have contributed to the inception of the idea, literature search, and writing/finalising this manuscript.
Corresponding author
Ethics declarations
Consent for publication
This is to confirm that this article has not been submitted or published elsewhere. The authors consent copyright transfer to European Journal of Pediatrics if approved for publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ahmed, M., Mansoor, N. & Mansoor, T. Review of eosinophilic oesophagitis in children and young people. Eur J Pediatr 180, 3471–3475 (2021). https://doi.org/10.1007/s00431-021-04174-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04174-0